is compounded semaglutide going away compound The End of Semaglutide? What The FDA's Decision Means for FDA is moving to restrict

A study from Washington University, released in January 2025, found that GLP-1s indeed were related to the decreased risk of suicidal ideation when compared with those not using these drugs

Occurrence of gastrointestinal adverse events upon GLP-1 receptor agonist initiation with concomitant metformin use: A post hoc analysis of LEADER, STEP 2, SUSTAIN-6, and PIONEER 6

Both products will be available to employers in January 2025.

It works by blocking estrogen receptors in the hypothalamus and pituitary, thereby reducing estrogens negative feedback and triggering the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH)

The clinic isnt licensed in Alabama, Alaska, Arizona, Arkansas, Delaware, Idaho, Kansas, Louisiana, Mississippi, New Hampshire, New Mexico, North Carolina, South Carolina, Utah, Vermont, West Virginia, or Wisconsin

Coverage depends on your insurance plan, diagnosis, pharmacy benefits, and prior authorization requirements